Richard Dilorio - 17 May 2022 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Chief Executive Officer, Director
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Richard Dilorio
Issuer symbol
INFU
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
17 May 2022, 17:10:20 UTC
Previous filing
24 Jan 2022
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INFU Common Stock 241,693 17 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFU Stock Option (right to buy) Award $0 +59,984 $0.000000 59,984 17 May 2022 Common Stock 59,984 $8.58 Direct F2, F3
transaction INFU Restricted Stock Units Award $0 +40,909 $0.000000 40,909 17 May 2022 Common Stock 40,909 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This total includes an additional 1,858 shares acquired recently through the Company's Employee Stock Purchase Plan
F2 The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.
F3 The option, representing the right to purchase a total of 59,984 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.
F4 Restricted stock units convert into common stock on a one-for-one basis.
F5 These restricted stock units will cliff vest on May 17, 2025.